• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读医疗机构中抗生素暴露患者艰难梭菌感染相对风险的潜在机制的重要性。

Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.

作者信息

Mitchell Christopher, Keegan Lindsay T, Le Thuy T T, Khader Karim, Beams Alexander, Samore Matthew H, Toth Damon J A

机构信息

Department of Mathematics, Tarleton State University, Stephenville, Texas, United States of America.

Division of Epidemiology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States of America.

出版信息

PLoS One. 2024 Aug 8;19(8):e0306622. doi: 10.1371/journal.pone.0306622. eCollection 2024.

DOI:10.1371/journal.pone.0306622
PMID:39116083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11309424/
Abstract

Clostridioides difficile infection (CDI) is a significant public health threat, associated with antibiotic-induced disruption of the normally protective gastrointestinal microbiota. CDI is thought to occur in two stages: acquisition of asymptomatic colonization from ingesting C. difficile bacteria followed by progression to symptomatic CDI caused by toxins produced during C. difficile overgrowth. The degree to which disruptive antibiotic exposure increases susceptibility at each stage is uncertain, which might contribute to divergent published projections of the impact of hospital antibiotic stewardship interventions on CDI. Here, we model C. difficile transmission and CDI among hospital inpatients, including exposure to high-CDI-risk antibiotics and their effects on each stage of CDI epidemiology. We derive the mathematical relationship, using a deterministic model, between those parameters and observed equilibrium levels of colonization, CDI, and risk ratio of CDI among certain antibiotic-exposed patients relative to patients with no recent antibiotic exposure. We then quantify the sensitivity of projected antibiotic stewardship intervention impacts to alternate assumptions. We find that two key parameters, the antibiotic effects on susceptibility to colonization and to CDI progression, are not identifiable given the data frequently available. Furthermore, the effects of antibiotic stewardship interventions are sensitive to their assumed values. Thus, discrepancies between different projections of antibiotic stewardship interventions may be largely due to model assumptions. Data supporting improved quantification of mechanistic antibiotic effects on CDI epidemiology are needed to understand stewardship effects better.

摘要

艰难梭菌感染(CDI)是一项重大的公共卫生威胁,与抗生素导致的正常保护性胃肠道微生物群破坏有关。CDI被认为分两个阶段发生:通过摄入艰难梭菌细菌获得无症状定植,随后发展为由艰难梭菌过度生长期间产生的毒素引起的有症状CDI。破坏性抗生素暴露在每个阶段增加易感性的程度尚不确定,这可能导致已发表的关于医院抗生素管理干预对CDI影响的预测存在差异。在此,我们对医院住院患者中的艰难梭菌传播和CDI进行建模,包括暴露于高CDI风险抗生素及其对CDI流行病学各阶段的影响。我们使用确定性模型推导这些参数与观察到的定植、CDI平衡水平以及某些抗生素暴露患者相对于近期未接触抗生素患者的CDI风险比之间的数学关系。然后,我们量化了预测的抗生素管理干预影响对替代假设的敏感性。我们发现,鉴于经常可用的数据,无法确定两个关键参数,即抗生素对定植易感性和CDI进展的影响。此外,抗生素管理干预的效果对其假设值很敏感。因此,抗生素管理干预不同预测之间的差异可能很大程度上归因于模型假设。需要支持更好地量化抗生素对CDI流行病学的机制性影响的数据,以更好地理解管理效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/852c7cc7e6a9/pone.0306622.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/dc6a4ba38825/pone.0306622.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/7845d1d3dbc7/pone.0306622.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/f374478d4f24/pone.0306622.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/06ed256eee79/pone.0306622.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/852c7cc7e6a9/pone.0306622.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/dc6a4ba38825/pone.0306622.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/7845d1d3dbc7/pone.0306622.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/f374478d4f24/pone.0306622.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/06ed256eee79/pone.0306622.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ab0/11309424/852c7cc7e6a9/pone.0306622.g005.jpg

相似文献

1
Importance of underlying mechanisms for interpreting relative risk of Clostridioides difficile infection among antibiotic-exposed patients in healthcare facilities.解读医疗机构中抗生素暴露患者艰难梭菌感染相对风险的潜在机制的重要性。
PLoS One. 2024 Aug 8;19(8):e0306622. doi: 10.1371/journal.pone.0306622. eCollection 2024.
2
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
3
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD003543. doi: 10.1002/14651858.CD003543.pub3.
4
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
5
Interventions to improve antibiotic prescribing practices for hospital inpatients.改善医院住院患者抗生素处方行为的干预措施。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
6
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
7
Dietary iron attenuates infection via modulation of intestinal immune response and gut microbiota.膳食铁通过调节肠道免疫反应和肠道微生物群来减轻感染。
Virulence. 2025 Dec;16(1):2529454. doi: 10.1080/21505594.2025.2529454. Epub 2025 Jul 16.
8
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.益生菌用于预防成人和儿童艰难梭菌相关性腹泻
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
9
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.抗生素管理对耐药菌感染和定植及艰难梭菌感染发生率的影响:系统评价和荟萃分析。
Lancet Infect Dis. 2017 Sep;17(9):990-1001. doi: 10.1016/S1473-3099(17)30325-0. Epub 2017 Jun 16.
10
Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence.预防地方性医疗保健相关艰难梭菌感染:回顾证据。
Am J Gastroenterol. 2010 Nov;105(11):2327-39; quiz 2340. doi: 10.1038/ajg.2010.254. Epub 2010 Jul 6.

本文引用的文献

1
Antibiotics Associated With Clostridium difficile Infection.与艰难梭菌感染相关的抗生素
Cureus. 2023 May 15;15(5):e39029. doi: 10.7759/cureus.39029. eCollection 2023 May.
2
Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.艰难梭菌(梭状芽孢杆菌属)源于人类的抗微生物药物耐药性:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2020 Sep 25;9(1):158. doi: 10.1186/s13756-020-00815-5.
3
Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.
碳青霉烯类和糖肽类药物的使用会增加接受强化诱导化疗的急性髓系白血病患者发生艰难梭菌感染的风险。
Ann Hematol. 2020 Nov;99(11):2547-2553. doi: 10.1007/s00277-020-04274-1. Epub 2020 Sep 24.
4
Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.建模针对医疗机构个体施用抗艰难梭菌感染疫苗的潜在影响。
Vaccine. 2020 Aug 18;38(37):5927-5932. doi: 10.1016/j.vaccine.2020.06.081. Epub 2020 Jul 21.
5
Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China.中国上海某 ICU 住院患者艰难梭菌感染和定植的危险因素。
BMC Infect Dis. 2019 Nov 11;19(1):961. doi: 10.1186/s12879-019-4603-1.
6
Recovery of gut microbiota of healthy adults following antibiotic exposure.健康成年人在接触抗生素后肠道微生物组的恢复。
Nat Microbiol. 2018 Nov;3(11):1255-1265. doi: 10.1038/s41564-018-0257-9. Epub 2018 Oct 22.
7
Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings.医疗机构中艰难梭菌传播控制的抗菌药物管理与环境去污
Bull Math Biol. 2017 Jan;79(1):36-62. doi: 10.1007/s11538-016-0224-7. Epub 2016 Nov 8.
8
Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis.系统评价和荟萃分析:随机对照试验中全身使用抗生素后艰难梭菌感染。
Int J Antimicrob Agents. 2016 Jul;48(1):1-10. doi: 10.1016/j.ijantimicag.2016.03.008. Epub 2016 Apr 27.
9
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?哌拉西林/他唑巴坦及其他对艰难梭菌具有抑制活性的抗生素是否会降低艰难梭菌定植的获得风险?
BMC Infect Dis. 2016 Apr 18;16:159. doi: 10.1186/s12879-016-1514-2.
10
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.艰难梭菌的抗药性和耐药性降低:对艰难梭菌感染的诱导、治疗和复发的潜在影响。
Antibiotics (Basel). 2015 Jul 10;4(3):267-98. doi: 10.3390/antibiotics4030267.